Brief: Moody's Says Amgen's And Horizon Therapeutics' Ratings Unaffected By FTC Recent Filing To Block The Acquisition
May 16 (Reuters) -
* MOODY'S: AMGEN'S AND HORIZON THERAPEUTICS' RATINGS
UNAFFECTED BY
FTC RECENT FILING TO BLOCK THE ACQUISITION
Source text for Eikon: ID:nMDY1bqSqb
Further company coverage: HZNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Horizon Therapeutics
See all newsDeals of the day-Mergers and acquisitions
Amgen completes $27.8 bln Horizon deal (updated)
Amgen completes acquisition of Horizon Therapeutics
Brief: Amgen Completes Acquisition Of Horizon Therapeutics PLC
On October 5, Court Sanctioned The Scheme Of Arrangement Under Chapter 1 Of Part 9 Of The Irish Companies Act 2014